Tag: Patient Risk

FDA designates Class 1 recall for IPV therapy system

Editor's Note The US Food and Drug Administration (FDA) has deemed the recall of Sentec Percussionaire’s Phasitron 5 In-Line Valve—a component of the manufacturer’s Intrapulmonary Percussive Ventilation (IPV) therapy system—a Class 1, the most severe category indicating serious risk of injury or death.   According to the agency’s October 2…

Read More

By: Matt Danford
October 3, 2024
Share

Alternative to mitral valve surgery shows promise, but research criticized

Editor's Note Although data suggest transcatheter edge-to-edge repair (TEER) using the MitraClip device may offer similar outcomes to mitral valve surgery in patients with heart failure and functional mitral regurgitation (FMR), experts have criticized the research, TCT MD reported September 1. Presented at the recent European Society of Cardiology (ESC)…

Read More

By: Matt Danford
September 23, 2024
Share

Study: Preoperative depression boosts risk of postoperative delirium

Editor's Note Patients with depressive symptoms are nearly twice as likely to experience delirium after major surgery, according to a meta-analysis published September 4 in the journal Anaesthesia. The evaluation of the link between preoperative depression and postoperative delirium included data from 42 studies involving more than 4.6 million patients.…

Read More

By: Matt Danford
September 11, 2024
Share

How perioperative staff can combat human trafficking—Part 1

Human trafficking (HT) is a global public health crisis and one of the fastest growing criminal enterprises that grosses hundreds of billions of dollars annually, all of which are tax-free profits made off the sale of human cargo. And yet, research shows the problem is poorly understood or recognized among…

Read More

By: Francine Bono-Neri, PhD, RN, APRN, PNP
August 28, 2024
Share

Study: Uterus transplant associated with high birth rates, but significant risks

JAMA (healthcare publication) Network logo

Editor's Note Uterus transplants are feasible, but the procedure is associated with considerable risks for both patient and organ donor, according to a study published August 15 in JAMA.   Conducted at a large US tertiary care center, the study involved 20 women with absolute uterine-factor infertility—a condition that prevents…

Read More

By: Matt Danford
August 16, 2024
Share

FDA announces Class 1 recalls for nerve monitoring system, ambulatory infusion pumps

Editor's Note The US Food and Drug Administration (FDA) designated recalls of Medtronic’s NIM Vital Nerve Monitoring System and Smith Medical’s CADD-Solis Ambulatory Infusion Pumps as Class 1, the most severe category indicating serious risk of injury or death. Reports of false negative responses prompted Medtronic to recall the nerve…

Read More

By: Matt Danford
August 7, 2024
Share

Study: Intraoperative DEX infusions effectively manage diabetes in cardiac surgery patients

Editor's Note Intraoperative infusion of dexmedetomidine (DEX) could help improve glycemic control and reduce insulin requirements in diabetic patients undergoing cardiac surgery, according to a July 25 article in Medical Dialogues. The article focuses on a prospective observational study published in the journal Annals of Cardiac Anesthesia. The study included…

Read More

By: Matt Danford
July 29, 2024
Share

FDA announces Class 1 recalls of ventilator, eye injection kits

Editor's Note The US Food & Drug Administration has designated recalls of Baxter’s Life2000 Ventilator and the I-Pack Injection Kit from Bausch + Lomb and subsidiary Synergetics Inc. as Class 1, the most severe category indicating serious risk of injury or death. According to FDA’s July 15 announcement, the ventilator…

Read More

By: Matt Danford
July 16, 2024
Share

Study: Gastric bypass offers cardiovascular benefits regardless of weight loss

Editor's Note Roux-en-Y gastric bypass (RYGB) reduces cardiovascular risk factors independent of calorie restriction and weight loss, according to a recent study published in JAMA Surgery. News-Medical.Net reported on the study July 4. Bariatric surgery, particularly RYGB, is more effective than non-surgical treatments for significant weight reduction and lowering cardiovascular…

Read More

By: Matt Danford
July 15, 2024
Share

Study: Secondary conditions go unaddressed in female heart surgery patients

Editor's Note Female patients undergoing heart surgery are less likely than male patients to have concomitant procedures—that is, having additional ailments addressed during cardiac procedures—despite guidelines recommending such treatments, according to two studies led by Michigan Medicine. News-Medical.Net reported the news June 28. The first study, involving over 5,000 patients…

Read More

By: Matt Danford
July 3, 2024
Share

Join our community

Learn More
Video Spotlight
Live chat by BoldChat